Company Description
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
The company provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
It also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences.
In addition, the company provides proactive and reactive product safety, litigation support, and technical, regulatory services.
It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors.
The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998.
The company was founded in 1967 and is headquartered in Menlo Park, California.
| Country | United States |
| Founded | 1967 |
| IPO Date | Aug 17, 1990 |
| Industry | Engineering & Construction |
| Sector | Industrials |
| Employees | 1,168 |
| CEO | Catherine Corrigan |
Contact Details
Address: 149 Commonwealth Drive Menlo Park, California 94025 United States | |
| Phone | 650 326 9400 |
| Website | exponent.com |
Stock Details
| Ticker Symbol | EXPO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000851520 |
| CUSIP Number | 30214U102 |
| ISIN Number | US30214U1025 |
| Employer ID | 77-0218904 |
| SIC Code | 8742 |
Key Executives
| Name | Position |
|---|---|
| Dr. Catherine Ford Corrigan P.E., Ph.D. | President, Chief Executive Officer and Director |
| Richard L. Schlenker Jr. | Executive Vice President, Chief Financial Officer and Corporate Secretary |
| Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. | Group Vice President |
| Dr. Joseph Rakow Ph.D. | Group Vice President |
| Dr. Joseph Sala Ph.D. | Group Vice President |
| Dr. Bernard Ross P.E., Ph.D. | Co-Founder, Chairman Emeritus and Principal Engineer |
| Eric R. Anderson | Vice President of Finance and Accounting |
| Dr. Subbaiah V. Malladi P.E., Ph.D. | Chief Technology Officer and Principal Engineer |
| Gina Flynn | Vice President of Legal and General Counsel |
| Brian Kundert | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 10, 2025 | 8-K | Current Report |
| May 27, 2025 | 144 | Filing |
| May 23, 2025 | 144 | Filing |
| May 20, 2025 | 144 | Filing |
| May 9, 2025 | 10-Q | Quarterly Report |
| May 1, 2025 | 8-K | Current Report |
| Apr 21, 2025 | ARS | Filing |
| Apr 21, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 18, 2025 | 10-K/A | [Amend] Annual report |
| Feb 28, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |